The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome
Clinical trial NCT02042482 · UNKNOWN
Trial details
- NCT number
- NCT02042482
- Sponsor
- Kaplan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.